UTokyo Innovation Platform Company

RoboTruck specializes in developing autonomous driving technologies for large trucks, aiming to address the logistics industry's driver shortage and environmental concerns. The company focuses on creating AI-powered, break-free autonomous trucks that reduce operational costs and enhance road safety. Their innovative solutions include bird's eye view transformers, generative AI for simulation, and vision-language models, enabling optimized supply chains and adaptive, fail-safe systems. RoboTruck's primary goal is to provide a sustainable and safe transportation system in Japan's logistics market.

Instalimb, Inc. is a pioneering company based in Tokyo, Japan, specializing in the development of low-cost 3D printed prosthetics and orthotics. Leveraging advanced 3D-CAD, 3D printing, and machine learning technologies, Instalimb aims to revolutionize the prosthetics industry by significantly reducing production costs and delivery times. The company utilizes an innovative algorithm that enhances design efficiency, allowing for the creation of customized prosthetic devices tailored to individual needs. This cutting-edge approach not only makes prosthetics more accessible to amputees but also represents a significant advancement in the field of assistive technology. As the world's first business dedicated to 3D printed prostheses, Instalimb is committed to improving the quality of life for individuals requiring these essential devices.

Ubitus Inc. is a technology company specializing in cloud computing solutions aimed at enhancing fixed-mobile convergence applications. Founded in 2007 and headquartered in Tokyo, with a research and development center in Taipei, Ubitus develops software platforms that enable device manufacturers and telecommunications service providers to facilitate the sharing of live content and access to digital media. Its notable products include ubiLive, a software client and web portal designed for content access and device connectivity, and robust mobile cloud gaming services. Ubitus is recognized for its innovative GameCloud technology, which allows for the streaming of not only gaming content but also metaverse experiences across multiple devices. The company has established strategic partnerships with major players, such as Alibaba Cloud and Kokusai Kogyo Co. Ltd., enhancing its capability to deliver advanced cloud-enabled rich media services.

Leading Mark Inc. is an employment agency based in Tokyo, Japan, specializing in human resources services. The company is focused on streamlining the recruitment process through its online platform, which aggregates job listings tailored to users' interests. This approach aims to enhance the job-seeking experience by prioritizing the needs of applicants, in contrast to larger, traditional agencies that may focus more on the hiring companies. Additionally, Leading Mark is expanding its operations to include mid-career and international hiring, with a dedicated team in China working to connect top Japanese-speaking Chinese students with domestic employers. By emphasizing a user-centric model, Leading Mark seeks to alleviate the frustrations often faced by job seekers, ensuring they receive the information and opportunities they need to advance their careers.

Developer of healthcare devices intended for weight management. The company's product is a bath mat that automatically tracks the weight of all the members of the family, records daily weight changes and provides data in the application synced with the mat and is equipped with various modes which fulfill the lifelong weight management needs of various stages of life including babies to elder people, enabling users to monitor their weight and body mass index for lifestyle improvement.

BlueWX is a technology company specializing in advanced weather forecast services. It leverages current research and artificial intelligence to enhance the precision of weather predictions, particularly for aviation. The company's services include detailed forecasts for flight routes, aiming to improve safety and operational efficiency for airlines and other aviation-related businesses. Additionally, BlueWX caters to industries that rely on accurate weather information for their operations.

OptQC specializes in commercializing advanced optical quantum computing technologies, originally developed by the Furusawa-Endo Laboratory. The company operates a quantum computing platform that leverages scalable optical quantum technology, offering significant advantages such as enhanced quantum bit scalability, reduced power consumption, and faster processing speeds. This positions OptQC's optical quantum computers as a potential long-term pinnacle in quantum technology, capable of handling complex computations with up to one million quantum bits, thereby enabling industrial applications to harness the power of quantum computing.

Orbital Lasers is a space technology company specializing in two primary business areas: space debris removal and satellite LiDAR. The company's core technology is a compact, efficient satellite laser designed for precise altitude measurements, supporting space exploration and various industries. This innovative laser reduces satellite weight and manufacturing costs, enabling small satellites to undertake advanced space tasks. For space debris removal, Orbital Lasers' technology facilitates efficient tracking and mitigation of orbital debris. In the LiDAR sector, the company provides surface data services, leveraging its laser technology to deliver accurate and detailed information.

OOYOO is a technology company specializing in the research and development of advanced gas separation membranes. Their primary focus is on carbon dioxide and hydrogen separation, aiming to create cleaner and more efficient air and gas purification solutions. The company's innovative, compact, and portable systems are designed to help industries reduce operational costs and promote sustainability, catering to sectors involved in environmental preservation and clean energy initiatives.

Visban is a technology company that specializes in utilizing millimeter wave (mmWave) signals for reliable and fast connectivity, both indoors and outdoors. Its core business involves providing network solutions that eliminate dead spots and offer uninterrupted connections, using fewer base stations than traditional methods. This results in more energy-efficient operations and extended battery life for mobile devices on the network. Visban's innovative approach integrates artificial intelligence (AI) with its radio frequency-on-glass (RF-on-glass) device, economically distributing mmWave signals to enhance network reliability and reduce deployment costs for both terrestrial and satellite-based networks.

EX4Energy is a telecommunications company that focuses on developing distributed energy interconnection infrastructure. This infrastructure is designed to facilitate the monitoring and control of distributed power systems, including solar power, storage batteries, and electric vehicle chargers. By connecting these systems, EX4Energy enables businesses to streamline the interconnection process, thereby supporting their transition to sustainable energy solutions. The company's efforts contribute to the promotion of a carbon-neutral world, making it a key player in the advancement of renewable energy technologies.

Trans-N is a Japanese business specializing in AI-driven digital transformation. It provides management consulting, develops AI systems, and sells AI tools such as meeting minutes and contract analysis software. The company primarily serves major trading firms, aiming to accelerate their AI adoption and enhance their competitiveness.

LiberoThera provides drug discovery research and development services. It focuses on making drugs with GPCRs for membrane proteins. LiberoThera was founded in 2018 and is located in Tokyo.

AceRNA Technologies is a biotechnology startup focused on developing patient-centric genetic therapies using its proprietary RNA switch technology for drug discovery. The company specializes in regenerative medicine, aiming to control gene expression with novel microRNA functions. Its innovative approach enables the removal of undifferentiated cells and other unnecessary cells that pose cancer risks, thereby advancing personalized healthcare solutions.

Girasol Energy Inc. is a Tokyo-based company established in 2017 that specializes in developing an IoT platform specifically for photovoltaic plants. The company’s innovative platform, PPLC, integrates sensor networks that collect solar radiation data using satellite statistics rather than traditional local pyranometers, allowing for widespread applicability across Japan. Its cloud engine processes this data at the panel level, automatically identifying abnormalities through an artificial intelligence-powered engine. Girasol Energy focuses on providing cost-effective monitoring solutions, enabling businesses to remotely detect degradation and optimize the performance of their solar panel modules.

HarvestX is a technology company that focuses on developing robotic solutions for the agricultural sector, specifically targeting the challenges of indoor vertical farming. Originating from a project at the University of Tokyo, the company aims to enhance fruit production through automation. HarvestX specializes in creating automated pollination robots, addressing a significant challenge in fruit cultivation. Its technology utilizes a depth camera and advanced image processing algorithms to identify flowers and fruits, facilitating effective pollination and harvesting. By implementing these innovations, HarvestX seeks to alleviate the labor shortages in agriculture and ensure a consistent and stable food supply.

Spectronix is a company dedicated to the development of innovative laser technologies and applications, specifically tailored for microprocessing and microfabrication. By focusing on advancements in laser technology, Spectronix aims to enhance manufacturing processes, offering faster processing speeds that vary according to the materials used. This efficiency allows manufacturers to achieve competitive pricing and reduced operational costs, positioning Spectronix as a key player in the laser technology sector.

TopoLogic is a company focused on advancing the application of topological materials, which are materials that exhibit unique properties derived from their geometric arrangement. The company specializes in the design, development, manufacturing, and sale of high-performance heat flux sensors and memory devices that leverage these materials. In addition to hardware, TopoLogic also provides software solutions that enhance the functionality of devices utilizing topological materials. By innovating in the realm of quantum science, TopoLogic aims to help businesses optimize energy utilization and perpetuation, thereby pushing the boundaries of what is achievable in energy efficiency and material science.

Yoii Fuel develops and operates the future assessment-type funding platform. It also offers a future assessment-type funding platform that assesses future sales based on past sales and financial data and provides funding.

QSimulate is a Boston-based company that specializes in developing cloud-based quantitative simulation tools focused on quantum molecular simulations. By leveraging the principles of quantum mechanics, QSimulate aims to address significant industrial-scale challenges primarily within the chemical and pharmaceutical sectors. Its innovative platform automates various workflows, allowing computational scientists to shift their focus from repetitive tasks to more strategic activities, ultimately enhancing productivity. This approach enables clients to accelerate their research and development processes, positioning QSimulate as a key player in advancing scientific inquiry and innovation in these industries.

Better Place is a company focused on creating a supportive environment for individuals working in sectors such as childcare and long-term care. By managing a defined benefit pension system, Better Place aims to enhance the welfare and financial security of those who contribute to societal development. The company's mission emphasizes the importance of kindness and aims to alleviate the financial concerns of employees, allowing them to work in their own way without the burden of monetary worries. Through its initiatives, Better Place seeks to ensure that clients can secure their employees' futures once they retire, thereby fostering a more compassionate and sustainable community.

Takumi Giken Kogyo is a developer of innovative price technology aimed at assisting parts manufacturers in efficiently determining suitable product prices. The company’s technology facilitates estimate calculations and enhances product functionality through features such as AI drawing search and the ability to identify repeat projects. This enables manufacturers to customize product functions flexibly according to specific customer requirements, ultimately streamlining the pricing and production processes.

Heartseed Inc. is a Tokyo-based biotechnology company founded in 2015, focused on developing myocardial regeneration medicine utilizing induced pluripotent stem (iPS) cells. The company's mission is to advance treatments for heart disease through regenerative medicine, specifically targeting advanced heart failure with iPS cell-derived cardiomyocyte replacement therapy. Heartseed aims to enable the clinical application of its innovative therapies to improve outcomes for patients suffering from heart conditions.

Logomix is a synthetic biology company that specializes in genome engineering through its innovative platform, Geno-Writing™. The company enables precise manipulation of genomic sequences within human cells, allowing for extensive genetic alterations targeting specific loci across megabases. This capability supports the development of advanced hypoimmune cells, addressing significant challenges in current cell therapy methods. Logomix's technology has the potential to revolutionize treatments for solid tumors and over 70,000 genetic diseases, representing a substantial market opportunity. By facilitating collaborations and partnerships in human cell engineering, Logomix aims to drive advancements in cell therapy and regenerative medicine.

BionicM is a Tokyo-based company that specializes in the research, development, and commercialization of advanced mobility devices that integrate robotics with the human body. Founded in 2018, BionicM focuses on creating high-performance robotic prostheses, including ankle-foot and knee joints, aimed at enhancing mobility for individuals with disabilities. The company has its roots in research conducted since 2015 at the University of Tokyo's Information Systems Engineering Laboratory, where it leveraged cutting-edge robotics technology under the guidance of Professor Inaba. BionicM's innovative solutions enable users, whether handicapped or non-handicapped, to perform daily activities such as standing, walking, and climbing stairs, thereby significantly improving their quality of life.

Storm Therapeutics Limited is a biotechnology company based in Cambridge, United Kingdom, focused on discovering and developing small molecule drugs that target RNA-modifying enzymes for cancer treatment and other immune diseases. Incorporated in 2015 and previously known as Iceni Therapeutics Limited, the company utilizes its drug discovery and RNA analytics platform to modulate RNA modifying enzymes, identifying novel targets and first-in-class drug candidates. Storm Therapeutics aims to provide innovative therapies against RNA epigenetic targets, addressing various conditions including oncology, inflammation, viral infections, and central nervous system diseases.

ImaCreate is a virtual reality company focused on developing training solutions that leverage virtual, augmented, and mixed reality technologies. It specializes in creating advanced training programs for industrial and medical applications, aiming to enhance the efficacy of learning experiences beyond traditional methods. The company is dedicated to embodied extended reality research and social implementation, striving to create an environment where individuals can work more freely and conveniently, transcending real-world limitations such as time and location. Through its innovative approach, ImaCreate seeks to redefine how training is conducted and to improve accessibility in various fields.

DEM BioPharma is an immuno-oncology company focused on developing innovative therapies to combat cancer by harnessing the innate immune system. The company is pioneering a platform dedicated to creating next-generation macrophage immunotherapies, which aim to activate macrophages and immune phagocytes to effectively target and eliminate tumors. By researching and targeting specific signals on both cancer cells and macrophages, DEM BioPharma seeks to provide healthcare researchers with advanced treatment options that enhance the body's ability to fight cancer.

Carbon Biosciences is a biotechnology company focused on developing genetic medicines aimed at treating serious diseases. The company utilizes a proprietary platform based on novel parvoviruses, which have been optimized through natural selection to effectively target specific tissues and deliver larger therapeutic cargoes. This technology is designed to minimize neutralizing immunity, allowing for potential re-dosing. Carbon Biosciences specifically targets lung tissues and has demonstrated success in preclinical models, including those for cystic fibrosis. Through its industrial-scale viral production platforms, the company aims to extend the reach of gene therapies, providing innovative solutions for previously challenging medical conditions.

Adacotech is a company focused on the development and manufacturing of advanced video surveillance systems and anomaly detection software. It offers a unique system that utilizes proprietary algorithms to monitor events continuously for 24 hours while maintaining real-time performance. Adacotech's technology incorporates capabilities for product inspection and abnormality detection in manufacturing processes, as well as the inspection of social infrastructure. By leveraging inputs from images, videos, sounds, and sensors, the company's solutions enable clients to conduct primary screenings effectively. The product development process is managed in-house, ensuring that all aspects, from the source technology to the application programming interface, are controlled by Adacotech.

Grand Green, established in 2017 and headquartered in Nagoya, Japan, specializes in the production of new seeds and seedlings through automatic grafting techniques. As a research and development agribio venture, the company focuses on innovative approaches to enhance agricultural practices and improve crop yield. By leveraging advanced technology in seedling production, Grand Green aims to contribute to the agricultural sector's growth and sustainability.

TopoLogic is a company focused on advancing the application of topological materials, which are materials that exhibit unique properties derived from their geometric arrangement. The company specializes in the design, development, manufacturing, and sale of high-performance heat flux sensors and memory devices that leverage these materials. In addition to hardware, TopoLogic also provides software solutions that enhance the functionality of devices utilizing topological materials. By innovating in the realm of quantum science, TopoLogic aims to help businesses optimize energy utilization and perpetuation, thereby pushing the boundaries of what is achievable in energy efficiency and material science.

Alivexis is a private preclinical stage drug discovery company based in Tokyo, specializing in the rapid design and generation of small molecule clinical candidates targeting high-value disease conditions. The company leverages advanced computational drug discovery techniques and unique biological insights to expedite the development of new medicines. Its international team comprises experts in drug design and disease biology, drawing on extensive research and development experience from global pharmaceutical, biotechnology, and technology firms. By focusing on innovative approaches, Alivexis aims to enhance biotechnological research and improve the efficiency of delivering essential medicines to patients with unmet medical needs.

Better Place is a company focused on creating a supportive environment for individuals working in sectors such as childcare and long-term care. By managing a defined benefit pension system, Better Place aims to enhance the welfare and financial security of those who contribute to societal development. The company's mission emphasizes the importance of kindness and aims to alleviate the financial concerns of employees, allowing them to work in their own way without the burden of monetary worries. Through its initiatives, Better Place seeks to ensure that clients can secure their employees' futures once they retire, thereby fostering a more compassionate and sustainable community.

Axial Biotherapeutics, Inc. is a biopharmaceutical company focused on developing therapeutics for central nervous system (CNS) diseases and disorders. Utilizing a microbiome discovery platform, the company targets the gut-brain axis to create innovative therapies aimed at improving the quality of life for patients suffering from neurological conditions. Founded in 2013 and headquartered in Waltham, Massachusetts, Axial Biotherapeutics is in the clinical stage of its development, working to advance its pipeline of novel CNS therapeutics.

TAGCyx Biotechnologies is a biotechnology company based in Tokyo, Japan, founded in 2007. It focuses on the development of novel nucleic acid-based drugs for therapeutic applications. The company has established its proprietary technology platform, Xenoligo, which utilizes genetic alphabet expansion through unnatural base pairs. This innovative approach allows for the creation of customized nucleic acids tailored specifically for therapeutic use, facilitating the discovery and development of high-functional oligonucleotide drugs. By leveraging this unique platform, TAGCyx aims to enhance treatment options for various diseases, thereby contributing to advancements in medical therapies.

VividQ Limited is a technology company based in Cambridge, United Kingdom, specializing in the development of software frameworks for generating, compressing, and transmitting 3D holographic images and video. The company offers a variety of products, including VividQ Capture, an API for converting 3D data into holographic formats, and VividQ Squeeze, a solution for compressing point cloud 3D data. Additionally, VividQ Core enables multi-user interactions with holograms at different focal planes, while VividQ View allows integration of various spatial light modulators into its holographic architecture. VividQ's advanced computational display technology aims to revolutionize digital displays by integrating holographic visuals into consumer electronics, augmented reality, virtual reality, and automotive applications. The company, which was formerly known as Penteract28 Limited before rebranding in 2017, collaborates with leading original equipment manufacturers to enhance user experiences in various sectors, including gaming, immersive simulations, and depth sensing.

Telexistence is a company focused on advancing robotics technology with a systematic approach aimed at creating scalable solutions. It specializes in the development of online remote control robotics that facilitate the transmission and analysis of visual, auditory, and tactile information. This technology allows users to interact and act in remote environments, thereby enhancing human presence in various contexts. By innovating in the field of robotics, Telexistence aims to provide new and effective ways for individuals to engage with the world remotely, pushing the boundaries of what is possible in robotic applications.

Heartseed Inc. is a Tokyo-based biotechnology company founded in 2015, focused on developing myocardial regeneration medicine utilizing induced pluripotent stem (iPS) cells. The company's mission is to advance treatments for heart disease through regenerative medicine, specifically targeting advanced heart failure with iPS cell-derived cardiomyocyte replacement therapy. Heartseed aims to enable the clinical application of its innovative therapies to improve outcomes for patients suffering from heart conditions.

LiberoThera provides drug discovery research and development services. It focuses on making drugs with GPCRs for membrane proteins. LiberoThera was founded in 2018 and is located in Tokyo.

Sonas Inc. is a Tokyo-based company specializing in the planning, design, manufacturing, and sale of innovative hardware and software solutions for sensing and measurement. The company is developing its UNISONet technology, which aims to enhance the Internet of Things (IoT) by providing high-quality wireless sensing capabilities. This technology addresses traditional challenges in IoT communications by utilizing advanced features such as power-saving mechanisms, high-speed data acquisition, low-latency bidirectional communication, and robust retransmission controls to prevent data loss. Sonas's solutions enable the sensing of various parameters, from small-scale measurements like temperature and humidity to larger-scale data such as acceleration and images, thereby positioning the company as a key player in the evolving IoT landscape.

ARAV is a manufacturer of innovative construction equipment that leverages robotics to enhance on-site safety and minimize risks in construction environments globally. The company's products are designed to be compatible with various construction machinery, allowing for remote operation through smartphones or laptops. This capability enables operators to control equipment such as digging and cutting tools from a distance, thereby reducing the physical burden on workers and promoting safer work practices. By retrofitting existing machinery, ARAV's solutions aim to improve efficiency and safety in construction sites, addressing common challenges faced in the industry.

RIN Institute Inc., established in 2016 and headquartered in Tokyo, Japan, specializes in research and development of medicines and external diagnostic drugs based on monoclonal antibodies. The company focuses on creating antibody-based treatments and diagnostics for various types of cancer, aiming to improve patient outcomes and recovery chances.

HarvestX is a technology company that focuses on developing robotic solutions for the agricultural sector, specifically targeting the challenges of indoor vertical farming. Originating from a project at the University of Tokyo, the company aims to enhance fruit production through automation. HarvestX specializes in creating automated pollination robots, addressing a significant challenge in fruit cultivation. Its technology utilizes a depth camera and advanced image processing algorithms to identify flowers and fruits, facilitating effective pollination and harvesting. By implementing these innovations, HarvestX seeks to alleviate the labor shortages in agriculture and ensure a consistent and stable food supply.

UrbanX Technologies, Inc. is a Tokyo-based company founded in 2020 that specializes in developing artificial intelligence solutions for road inspection. The company's technology identifies and detects road damage points, enabling local governments to monitor and maintain road conditions more efficiently. By utilizing AI for spatial recognition and digitization of real assets, UrbanX Technologies enhances the accuracy and speed of inspections, reducing reliance on traditional visual assessments. This innovative approach not only streamlines the inspection process but also aids in optimizing traffic flows and improving urban management.

BionicM is a Tokyo-based company that specializes in the research, development, and commercialization of advanced mobility devices that integrate robotics with the human body. Founded in 2018, BionicM focuses on creating high-performance robotic prostheses, including ankle-foot and knee joints, aimed at enhancing mobility for individuals with disabilities. The company has its roots in research conducted since 2015 at the University of Tokyo's Information Systems Engineering Laboratory, where it leveraged cutting-edge robotics technology under the guidance of Professor Inaba. BionicM's innovative solutions enable users, whether handicapped or non-handicapped, to perform daily activities such as standing, walking, and climbing stairs, thereby significantly improving their quality of life.

Adriakaim Inc. is a Tokyo-based company established in 2018 that specializes in the research, design, development, manufacture, and sale of medical and health-related equipment. In addition to its core product offerings, Adriakaim provides consulting services focused on management and technology strategy, specifically within the medical device sector. The company also supports research and development processes, contributing to advancements in healthcare technology.

Spectronix is a company dedicated to the development of innovative laser technologies and applications, specifically tailored for microprocessing and microfabrication. By focusing on advancements in laser technology, Spectronix aims to enhance manufacturing processes, offering faster processing speeds that vary according to the materials used. This efficiency allows manufacturers to achieve competitive pricing and reduced operational costs, positioning Spectronix as a key player in the laser technology sector.

Fimecs is a biotechnology company that specializes in drug discovery focused on protein degradation technology. The firm aims to develop first-in-class therapeutics targeting the degradation of proteins associated with cancers and other challenging diseases. Utilizing a proprietary platform based on ubiquitin E3 ligase binders, Fimecs designs small molecules that can induce the degradation of specific proteins, many of which are considered undruggable. This innovative approach targets proteins linked to various diseases, expanding the potential for effective treatment options beyond the traditionally druggable targets identified in small molecule drug discovery. Through its emphasis on targeted protein degradation, Fimecs is positioned to contribute significantly to the advancement of anti-cancer therapies and the treatment of other hard-to-treat conditions.

Onedot Inc. is a Tokyo-based company founded in 2016 that operates an online platform providing resources related to childcare. The company specializes in offering easy-to-understand baby food recipes, one-minute instructional videos, and information on childcare practices. Additionally, Onedot provides guidance on making handmade goods, along with introductions to childcare products and educational toys. One of its key services is Babily, a video platform designed to assist parents in navigating childcare challenges.

Alivexis is a private preclinical stage drug discovery company based in Tokyo, specializing in the rapid design and generation of small molecule clinical candidates targeting high-value disease conditions. The company leverages advanced computational drug discovery techniques and unique biological insights to expedite the development of new medicines. Its international team comprises experts in drug design and disease biology, drawing on extensive research and development experience from global pharmaceutical, biotechnology, and technology firms. By focusing on innovative approaches, Alivexis aims to enhance biotechnological research and improve the efficiency of delivering essential medicines to patients with unmet medical needs.

TAGCyx Biotechnologies is a biotechnology company based in Tokyo, Japan, founded in 2007. It focuses on the development of novel nucleic acid-based drugs for therapeutic applications. The company has established its proprietary technology platform, Xenoligo, which utilizes genetic alphabet expansion through unnatural base pairs. This innovative approach allows for the creation of customized nucleic acids tailored specifically for therapeutic use, facilitating the discovery and development of high-functional oligonucleotide drugs. By leveraging this unique platform, TAGCyx aims to enhance treatment options for various diseases, thereby contributing to advancements in medical therapies.

Aidemy Inc. is a Tokyo-based company that specializes in providing online artificial intelligence (AI) programming services and solutions. Founded in 2014, Aidemy offers an all-in-one web platform where individuals can learn AI technology through practical applications. The platform includes comprehensive teaching materials and a programming execution environment, enabling users to engage with AI concepts, such as blockchain technology and consensus algorithms. Aidemy's services cater to various clients, including corporations in the manufacturing industry, small businesses, and university laboratories. In addition to its educational offerings, the company provides Aidemy Business, an online learning platform designed to support the development of digital talent and reskilling efforts within organizations. Furthermore, Aidemy offers Modeloy, a DX consulting service that assists companies in human resource development, problem selection, and the implementation of digital transformation initiatives.

AccuRna, Inc. is a biotechnology company based in Tokyo, Japan, specializing in the research and development of nucleic acid-based drugs through advanced drug delivery systems. Founded in 2015, the company aims to advance therapeutic innovation by utilizing its robust drug delivery system platform to provide effective treatments for refractory diseases, which currently lack cures. AccuRna focuses on developing technologies that facilitate the delivery of various nucleic acid therapeutics, including siRNA, ASO, miRNA, mRNA, and CRISPR-CAS. By ensuring safe and efficient delivery of these therapies, AccuRna endeavors to provide radical cures for patients worldwide suffering from challenging medical conditions.

WealthNavi Inc., established in 2015 and based in Tokyo, Japan, specializes in developing and delivering a cloud-based online platform for asset management and risk management. This platform offers robo-advisory services, enabling users to discover diversified investment opportunities globally. The company's core offering is a risk management algorithm-driven platform designed to assist asset managers in their decision-making processes.

Synspective Inc., headquartered in Tokyo, Japan, specializes in providing data solutions by leveraging synthetic aperture radar (SAR) satellite constellations, big data, and machine learning. The company serves a variety of markets, including urban design, infrastructure, energy, insurance, finance, and government agencies. Synspective offers remote monitoring services and satellite imagery using small-sized SAR satellites, which can measure human activity over wide areas on Earth, unaffected by time or weather conditions. This technology supports clients in achieving sustainable development and resilient urban development goals.

Connected Robotics Inc., founded in 2014 and based in Koganei-shi, Japan, specializes in designing and manufacturing robotic arms for enterprises. Their flagship product, OctoChef, is a cooking robot designed to address labor shortages in the restaurant industry. Utilizing artificial intelligence, image processing, and robot control technologies, OctoChef aims to enhance efficiency and worker satisfaction by automating kitchen tasks. The company serves a variety of clients, including individual restaurants, shopping malls, stations, service areas, amusement centers, and large-scale events, providing fun and healthy meal options while contributing to societal improvements.

Astroscale, established in 2013, is a Singapore-based company that specializes in developing technologies to address the growing issue of space debris. It offers two primary services: End-of-Life Service by Astroscale (ELSA), a spacecraft retrieval service for satellite operators, and Active Debris Removal (ADR), which focuses on clearing larger, more dangerous debris. Additionally, Astroscale designs and manufactures the Lunar Dream Capsule, a time capsule intended for delivery to the moon. The company's mission is to create sustainable space systems and mitigate the hazards posed by orbital debris through innovative and scalable solutions.

EdiGENE Japan, now known as Modalis Therapeutics Corporation, is an emerging biotechnology company based in Tokyo, Japan. Founded in 2016, it specializes in the research and development of innovative therapeutics aimed at addressing serious genetic disorders. The company utilizes its proprietary CRISPR-GNDM technology, which allows for locus-specific modulation of gene expression and histone modification without the necessity for double-stranded DNA cleavage or traditional gene editing techniques. Modalis Therapeutics has established a solid intellectual property foundation, including licenses from the University of Tokyo, to support its focus on developing treatments for orphan genetic diseases and other unmet medical needs.

QD Laser, Inc. is a manufacturer of quantum dot semiconductor lasers and wafers, utilizing GaAs substrates for various applications in communications and industry. Established in 2006 and based in Kawasaki, Japan, the company specializes in creating a diverse range of high-performance laser products, including picosecond short-pulse DFB lasers for precision processing, current injection-type lasers in green, yellow-green, and orange for biological sciences, and quantum dot laser arrays for silicon optical circuits. Additionally, QD Laser produces broadband gain chips for ophthalmic testing and retinal imaging laser eyewear. Their technology serves multiple sectors, including telecommunications, manufacturing, medicine, and consumer products, allowing for advancements in fields like silicon photonics, sensing, and precision machining.

Crewt Medical Systems, established in Tokyo, Japan in 2013, specializes in manufacturing innovative medical devices. The company's flagship product is the world's first head-mounted perimeter, designed to meet clinical needs and compatible with standard automated perimeters. Crewt's mission is to create new value in healthcare by integrating advanced technologies, focusing on human-centric solutions that enhance visual quality.

Astroscale, established in 2013, is a Singapore-based company that specializes in developing technologies to address the growing issue of space debris. It offers two primary services: End-of-Life Service by Astroscale (ELSA), a spacecraft retrieval service for satellite operators, and Active Debris Removal (ADR), which focuses on clearing larger, more dangerous debris. Additionally, Astroscale designs and manufactures the Lunar Dream Capsule, a time capsule intended for delivery to the moon. The company's mission is to create sustainable space systems and mitigate the hazards posed by orbital debris through innovative and scalable solutions.

Axelspace Corporation, founded in 2008 and based in Tokyo, Japan, specializes in the design, manufacture, and sale of micro-satellites and their components for both domestic and international markets. The company focuses on remote-sensing applications, with notable projects including the GRUS satellite constellation for Earth observation, WNISAT-1R for sea ice monitoring, and Hodoyoshi-1, which captures high-resolution images of the ground. Axelspace also develops various micro-satellite components such as sensors for attitude determination and GPS receivers for positioning. The firm aims to create a cost-effective global monitoring platform that provides daily coverage, enhancing access to quality satellite imagery. In addition to satellite development, Axelspace offers operational support and launch arrangements for its micro-satellites, positioning itself as a key player in the microsatellite industry.

Synspective Inc., headquartered in Tokyo, Japan, specializes in providing data solutions by leveraging synthetic aperture radar (SAR) satellite constellations, big data, and machine learning. The company serves a variety of markets, including urban design, infrastructure, energy, insurance, finance, and government agencies. Synspective offers remote monitoring services and satellite imagery using small-sized SAR satellites, which can measure human activity over wide areas on Earth, unaffected by time or weather conditions. This technology supports clients in achieving sustainable development and resilient urban development goals.

Telexistence is a company focused on advancing robotics technology with a systematic approach aimed at creating scalable solutions. It specializes in the development of online remote control robotics that facilitate the transmission and analysis of visual, auditory, and tactile information. This technology allows users to interact and act in remote environments, thereby enhancing human presence in various contexts. By innovating in the field of robotics, Telexistence aims to provide new and effective ways for individuals to engage with the world remotely, pushing the boundaries of what is possible in robotic applications.

QD Laser, Inc. is a manufacturer of quantum dot semiconductor lasers and wafers, utilizing GaAs substrates for various applications in communications and industry. Established in 2006 and based in Kawasaki, Japan, the company specializes in creating a diverse range of high-performance laser products, including picosecond short-pulse DFB lasers for precision processing, current injection-type lasers in green, yellow-green, and orange for biological sciences, and quantum dot laser arrays for silicon optical circuits. Additionally, QD Laser produces broadband gain chips for ophthalmic testing and retinal imaging laser eyewear. Their technology serves multiple sectors, including telecommunications, manufacturing, medicine, and consumer products, allowing for advancements in fields like silicon photonics, sensing, and precision machining.

Braizon Therapeutics, Inc. is a biopharmaceutical company based in Tokyo, Japan, founded in 2015. It focuses on the research and development of innovative drug delivery technologies specifically aimed at treating central nervous system disorders. The company was established through collaborative research efforts led by prominent academics from the University of Tokyo and Tokyo Medical and Dental University. Braizon’s primary objective is to create effective methods for delivering therapeutic drugs across the blood-brain barrier, thereby addressing the challenges associated with treating incurable neuronal diseases. Through its advanced platform, Braizon Therapeutics seeks to enhance the efficacy of treatments for patients suffering from various central nervous system conditions.

TAGCyx Biotechnologies is a biotechnology company based in Tokyo, Japan, founded in 2007. It focuses on the development of novel nucleic acid-based drugs for therapeutic applications. The company has established its proprietary technology platform, Xenoligo, which utilizes genetic alphabet expansion through unnatural base pairs. This innovative approach allows for the creation of customized nucleic acids tailored specifically for therapeutic use, facilitating the discovery and development of high-functional oligonucleotide drugs. By leveraging this unique platform, TAGCyx aims to enhance treatment options for various diseases, thereby contributing to advancements in medical therapies.

AccuRna, Inc. is a biotechnology company based in Tokyo, Japan, specializing in the research and development of nucleic acid-based drugs through advanced drug delivery systems. Founded in 2015, the company aims to advance therapeutic innovation by utilizing its robust drug delivery system platform to provide effective treatments for refractory diseases, which currently lack cures. AccuRna focuses on developing technologies that facilitate the delivery of various nucleic acid therapeutics, including siRNA, ASO, miRNA, mRNA, and CRISPR-CAS. By ensuring safe and efficient delivery of these therapies, AccuRna endeavors to provide radical cures for patients worldwide suffering from challenging medical conditions.

Alivas Inc. is a medical company focused on developing therapeutic medical devices specifically designed to treat refractory constipation. Founded in 2017, the company is based in Hongo, Tokyo, Japan. Alivas is a collaborative venture between Stanford University and the University of Tokyo, leveraging the Japan Biodesign program to foster innovation in medical device creation. The company's device aims to provide effective treatment solutions for patients suffering from intractable chronic constipation, helping them alleviate their condition and improve their quality of life.

Xenoma, Inc. is a Tokyo-based company specializing in the development of e-skin technology, which integrates wearable electronics into apparel. As a spin-off from the University of Tokyo's Someya Group Organic Transistor Lab, Xenoma leverages advancements in organic electronics to create ultrathin and flexible devices that can seamlessly interface with the human body. The company's innovative clothing line incorporates highly sensitive motion sensors capable of monitoring movement, posture, breathing, and body temperature, while also being durable and machine washable. By collecting accurate data from these sensors, Xenoma aims to enhance healthcare through the integration of big data and IoT solutions, ultimately providing users with comfortable and functional wearable technology.

Crewt Medical Systems, established in Tokyo, Japan in 2013, specializes in manufacturing innovative medical devices. The company's flagship product is the world's first head-mounted perimeter, designed to meet clinical needs and compatible with standard automated perimeters. Crewt's mission is to create new value in healthcare by integrating advanced technologies, focusing on human-centric solutions that enhance visual quality.